# Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer

> **NCT02415387** · EARLY_PHASE1 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 172 (actual)

## Conditions studied

- Cognitive Side Effects of Cancer Therapy
- Depression
- Recurrent Breast Carcinoma
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage IIA Breast Cancer
- Stage IIB Breast Cancer
- Stage IIIA Breast Cancer

## Interventions

- **BIOLOGICAL:** typhoid vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02415387
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-01
- **Primary completion:** 2021-04-27
- **Final completion:** 2021-04-27
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415387, "Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02415387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*